Tech Company Financing Transactions
Mekonos Funding Round
Mekonos secured a $4.6 million funding round on 12/7/2020. Investors included Novartis BioVenture Fund, CRCM and Elementum Ventures.
Transaction Overview
Company Name
Announced On
12/7/2020
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the new capital to accelerate the SoC platform for its current and new commercial partnerships.
Company Information
Company Status
Private & Independent
Industry
Security
Mailing Address
44 Montgomery St.
San Francisco, CA 94104
USA
San Francisco, CA 94104
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Building the future of cell therapies on a chip. Mekonos is creating a proprietary cell-engineering platform, using scalable silicon technology, for hyper-precise ex vivo delivery of molecules into any type of cell.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anil Narasimha
VP - Bus. Development
Milad Alucozai
VP - Engineering
Mark Webb
VP - Operations
Nova Syed
Browse more venture capital transactions:
Prev: 12/7/2020: Esports One venture capital transaction
Next: 12/7/2020: Correlia Biosystems venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs